← Eichor
Study identifier: NCT07610408 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparison of IV Analgesia Protocols After the Regional Block's Effect Diminishes in Thoracic Surgery

Condition: Postoperative Pain After Thoracic Surgery · Postoperative Pain · Thoracic Surgery, Video Assisted  ·  Sponsor: Ankara Etlik City Hospital

PhaseNA
Planned participants135
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The purpose of this study is to compare the effectiveness of three different intravenous (IV) patient-controlled analgesia (PCA) regimens-Fentanyl, Tramadol, and Ibuprofen-in managing postoperative pain and respiratory performance in patients undergoing Video-Assisted Thoracoscopic Surgery (VATS). While regional blocks like Erector Spinae Plane (ESP) block provide effective early analgesia, their effect typically diminishes after 8-12 hours, leading to potential 'rebound pain.' This study specifically investigates the period following the duration of the regional block's action. The primary goal is to evaluate which IV PCA protocol better controls pain (Visual Analog Scale scores) and supports better respiratory performance (measured by incentive spirometry) during the first 72 hours post-surgery

This description comes directly from the study's public registry record.

Talk to the study team

Baris Turunc, MD  ·  +90 5300202777  ·  baris.turunc94@gmail.com

Dilek Unal, MD, Prof.  ·  +90 5336957855  ·  dilekunalmd@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Ankara Etlik City Hospital, Department of Anesthesiology and ReanimationAnkara, Keçiören, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07610408